| 查看: 1108 | 回复: 2 | |||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | |||
[交流]
【求助】氧化型谷胱甘肽二钠注射液的原研商信息或其他文献均可
|
|||
|
求助:氧化型谷胱甘肽二钠注射液由俄罗斯 Pharma BAM公司生产。 英文名称:Glutatione oxidized disodium salt 的相关文献及资料。万分感谢各位。 |
» 猜你喜欢
如何高效的测量腺病毒的粒径和电位
已经有0人回复
26在职申博—生物与医药—抗体/ADC药物方向,江浙沪,有项目,可带资。
已经有1人回复
药理学论文润色/翻译怎么收费?
已经有79人回复
288分求调剂
已经有0人回复
一志愿苏州大学 生物技术与工程(086001) 初试323分,求调剂
已经有0人回复
三年实验室工作经历,一志愿华中农业大学微生物,总分288求调剂
已经有5人回复
070700求调剂
已经有1人回复
求调剂总分327
已经有1人回复
BL21(DE3)UV或者丝裂霉素诱导条件下会释放DE3的噬菌体吗?
已经有14人回复
» 抢金币啦!回帖就可以得到:
国自然申报交流祈福
+4/222
工科男,工作稳定,希望能遇到有趣的她
+1/174
2026年江西师范大学流动化学与工程研究院陈芬儿院士团队化学博士招生
+3/98
环境工程专业实习生|纯科研
+1/80
安农大李亚辉教授招收化学、生物、农药学、植保类方向申请考核制博士生
+3/59
双一流高校-南京林业大学-化学工程学院-国家海外优青团队招2026级博士(5月15号截止)
+1/50
西北工业大学物理科学与技术学院-诚聘【AI与光学交叉方向】博士后
+1/31
2026年江西师范大学药学院陈芬儿院士课题组招收智能药学博士生
+1/31
水处理技术员
+1/30
诚征女友,坐标西安
+1/29
类器官/器官芯片 华西医院有编制研究员招聘
+1/16
北京大学新材料学院招聘柔性电子方向博士后
+2/12
河南省医学科学院王宁利院士科研团队2026年博士、博后、硕士招聘
+1/9
招收2026年秋季入学博士生1名(河北工业大学/北京科技大学联合 增材制造/生物材料)
+1/6
科研服务:病毒包装、细胞系构建、蛋白表达、基因编辑
+1/4
湘潭大学材料学院“特种化学电源”创新团队补招2026年秋入学博士生
+1/4
2026年宁夏大学材料与新能源学院王海龙教授团队博士招生
+1/2
大湾区大学-中山大学联培博士招生(电磁方向)
+1/2
985院长团队!(大连理工,光电融合芯片方向) 招收2026秋入学博士生 5月初截止!
+1/1
华南理工大学材料学院招收2026年博士生(有机、高分子合成、二氧化碳转化)
+1/1
3楼2010-12-19 14:47:59
★
koria0727(金币+1):多谢参与。 2010-12-17 09:18:13
hypharm(金币+5): 2010-12-19 14:48:19
koria0727(金币+1):多谢参与。 2010-12-17 09:18:13
hypharm(金币+5): 2010-12-19 14:48:19
|
1题目Role of oxidative stress and intracellular glutathione in the sensitivity to apoptosis induced by proteasome inhibitor in thyroid cancer cells. Authors:du ZX; Zhang HY; Meng X; Guan Y; Wang HQ Abstract: BACKGROUND: The proteasome inhibitor bortezomib has shown impressive clinical activity alone and in combination with conventional and other novel agents for the treatment of multiple myeloma (MM) and some solid cancers. Although bortezomib is known to be a selective proteasome inhibitor, the downstream mechanisms of cytotoxicity and drug resistance are poorly understood. METHODS: Proteasome activity, intracellular glutathione (GSH) and ROS levels, as well as activities of GSH synthesis enzymes were measured using spectrophotometric methods. Cell death was analyzed using flow cytometry and caspase activity assay. The expression level of GSH synthesis enzymes were measured using real-time RT-PCR. RESULTS: At concentrations that effectively inhibited proteasome activity, bortezomib induced apoptosis in FRO cells, but not in ARO cells. Bortezomib elevated the amount of glutathione (GSH) and the treatment with bortezomib increased the level of mRNA for GCL, a rate-limiting enzyme in glutathione synthesis. Furthermore, depletion of GSH increases apoptosis induced by bortezomib, in contrast, repletion of GSH decreases bortezomib-mediated cell death. CONCLUSION: GSH protects cells from proteasome inhibition-induced oxidative stress and glutathione-dependent redox system might play an important role in the sensitivity to proteasome inhibition-induced apoptosis. Source:BMC Cancer [BMC Cancer] 2009; Vol. 9, pp. 56. Date of Electronic Publication: 2009 Feb 16 2Impairment of endothelial function induced by glyc-oxidized lipoprotein a [Lp(a)]. Authors:Galle J; Winner B; Conzelmann E; Wanner C Source:Cellular And Molecular Biology (Noisy-Le-Grand, France) [Cell Mol Biol (Noisy-le-grand)] 1998 Nov; Vol. 44 (7), pp. 1035-45. Abstract:diabetic patients develop endothelial dysfunction early in the course of the disease. Atherogenic lipoproteins such as LDL and Lp(a) are important risk factors for endothelial dysfunction and undergo nonenzymatic glycation in hyperglycaemia. Here we assessed whether glycation of Lp(a) potentiates its damaging influence on endothelial function. Human Lp(a) was glycated by dialyzation for 7 days against buffer containing 200 mmol/l glucose, or sham-treated without glucose and oxidized by incubation with Cu++. The degree of glycation accounted to 32 +/- 4%, and glycation rendered Lp(a) more susceptible to oxidative modification when exposed to Cu++. Isolated rings of rabbit aorta were superfused with physiological salt solution, and isometric tension was recorded. Incubation of the aortic rings with sham-treated or with 30 microg/ml glycated Lp(a), not oxidized, had no influence on acetylcholine-induced, endothelium-dependent relaxation. Exposure of the aortic rings to 30 microg/ml oxidized non-glycated (ox) Lp(a) caused a significant inhibition (19% at 1 microM acetylcholine) of the endothelium-dependent relaxation. Incubation of aortic rings with 30 microg/ml oxidized glycated (glyc-ox) Lp(a) attenuated endothelium-dependent relaxation more potently than oxLp(a) (by 34% at 1 microM acetylcholine). The presence of diethyl-dithio-carbamate (DDC), an inhibitor of the endogenous superoxide dismutase (SOD), potentiated the inhibition of relaxation induced by oxLp(a) and by glyc-oxLp(a) [38% inhibition at 1 microM acetylcholine for oxLp(a), and 49% inhibition at 1 microM acetylcholine for glyc-oxLp(a)]. Co-incubation with the O2- scavenger 4,5-dihydroxy-1,3-benzene disulfonic acid disodium salt (TIRON) prevented the inhibition of relaxation by the oxidized lipoproteins, suggesting that enhanced NO-inactivation by O2- could be the underlying mechanism for the impairment of endothelium-dependent dilations by ox- and glyc-oxLp(a). The concentration of lysophosphatidycholine, a lipoprotein oxidation product and stimulus for O2- formation, was significantly enhanced in oxLp(a) and in glyc-oxLp(a) compared to native lipoproteins. Conclusion: Glycation enhances the endothelium-damaging influence of oxLp(a), presumably by enhancing oxidative stress. The likely mechanism for attenuation of endothelium-dependent dilations is increased formation of O2-, resulting in inactivation of nitric oxide. This mechanism may play an important role in diabetic patients and may contribute to disturbed organ perfusion. [ Last edited by ronalbeck on 2010-12-16 at 14:45 ] |
2楼2010-12-16 14:43:58












回复此楼
